Global Veterinary Stereotactic Radiosurgery Market Set for Rapid Growth, to reach Value around USD 7.40 Billion By 2032

Zion Market Research has published a new report titled “Veterinary Stereotactic Radiosurgery Market By Modality (Cyber Knife, Gamma Knife, LINAC, PBRT and Others), By Product (Microsurgical Instrumentation, Optical/Viewing Instruments and Others), and By Region – Global Industry Perspective Comprehensive Analysis and Forecast, 2024 - 2032”. According to the report, the global veterinary stereotactic radiosurgery market size was valued at approximately USD 3.09 billion in 2023 and is predicted to reach around USD 7.40 billion by the end of 2032, expanding at a CAGR of around 10.2% from 2024 to 2032.

Browse the full “Veterinary Stereotactic Radiosurgery Market By Modality (Cyber Knife, Gamma Knife, LINAC, PBRT and Others), By Product (Microsurgical Instrumentation, Optical/Viewing Instruments and Others), and By Region – Global Industry Perspective Comprehensive Analysis and Forecast, 2024 - 2032” Report at https://www.zionmarketresearch.com/report/veterinary-stereotactic-radiosurgery-market

Stereotactic radiation surgery (SRS) is a kind of radiation therapy that uses highly powered forms of energy in a concentrated area of the body. Despite its name, SRS is not a surgical procedure, and is most commonly used to treat tumors that can not be surgically removed. Stereotactic radiosurgery is an advanced form of radiation therapy that delivers large doses of radiation in a short period of time, killing the tumor without damaging the healthy tissue around it. This proactive approach leads to faster tumor reduction, faster cancer-caused pain relief and very often provides better disease control for larger tumors.

Increasing pet population coupled with high cancer prevalence in them further escalates the market for veterinary stereotactic radiosurgery systems. For instance, in 2019, according to the Veterinary Cancer Society, cancer was the principal cause of mortality causing deaths of 47% of dogs over age of 10 years and 32% of cats. Therefore, the rising cases of cancer are chief to demand for an effective stereotactic radiosurgery treatment for companion animals. Another growth driver for the industry is growing adoption of retrofitted stereotactic devices for veterinary use to curb high procedural costs. Refurbished products benefit the owners of pets by lowering the cost of care while increasing adoption in the near future.

The market for Veterinary Stereotactic Radiosurgery is segmented based on modality and region. Based on the Modality segment, the market is bifurcated into Cyber Knife, Gamma Knife, LINAC, PBRT and Others. Particle Beam Radiation Therapy (PRBT) held the biggest market share of revenues in 2023. Some of the segment's key growth factors are advantages such as decreased irradiation for healthy tissue, and effective treatment even at low radiation dose. PRBT delivers the radiation dose on a tumor cell and deliberates on the surrounding tissue and organs with very little or no irradiation effect, according to a 2018 article in the Journal of Hematology & Oncology, Proton Beam Terapy for Cancer in the Age of Precision Medicine. The treatment leads to maximum tumor control, and ultimately reduces tumor toxicity. PBRT has been adopted by LINAC based stereotactic radiosurgery therapy, due to its increased adoption for veterinary use. The Veterinary CyberKnife Cancer Center installed a linear Varian accelerator in 2017 to treat dogs with cancerous tumours. The mounted LINAC system supplemented the CyberKnife software for the irradiation of various forms of cancer. Increasing the use of the LINAC-based radiosurgery system as a method of animal treatment fosters the development of veterinary stereotactic radiosurgery system demands.

Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. North America is anticipated to dominate the market over the forecast period, owing to the rising incidence of cancer in the pet population, growing pet companionship along with an increased willingness to spend on their pets, and government initiatives to treat SRT. The presence of non-profit organizations such as APPA catering to the needs and desires of pet products and services further drive regional market growth. Increasing research studies to test the safety and effectiveness of SRT in animals also drive market growth for North America. As regards the revenue over the forecast period, the second largest geographic segment is expected to be the European market for veterinary stereotactic radiosurgery systems. Factors expected to drive development are government R&D programs and the creation of new centers to conduct veterinary radiation oncology research activities. Asia Pacific had the third largest market share in 2023 and is projected to see substantial growth over the forecast period due to increased knowledge of various pet treatment methods and a willingness to spend more on veterinary health awareness programs. Due to the growing incidence of euthanasia and pet subscription, the Middle East and Africa retained a very small market share of SRT care, and the pet industry remains resilient over the years despite the economic and political issues in the region.

Some of the players included in Veterinary Stereotactic Radiosurgery market are Accuray, Elekta AB, PetCure Oncology, and Varian Medical Systems amongst others.

The report segments the Veterinary Stereotactic Radiosurgery market as follows:

Global Veterinary Stereotactic Radiosurgery Market: Modality Segment Analysis

• Cyber Knife
• Gamma Knife
• LINAC
• PBRT
• Others

Global Veterinary Stereotactic Radiosurgery Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com